text
"[""\nX. 대주주 등과의 거래내용\n가. 대주주 등에 대한 신용공여 등해당사항 없습니다.나. 대주주와의 자산양수도 및 영업거래 등보고서 작성기준일 현재 회사의 대주주 및 특수관계자 등에 대한 재화의 판매 또는 용역의 제공과 구입내역은 다음과 같습니다. 자세한 내역은 'III. 재무에 관한 사항 - 3. 연결재무제표 주석 - 23. 특수관계자 거래'를 참고하시기 바랍니다.[당분기]\n(단위: 천원)\n구 \xa0분\n회사명\n수익 등\n비용 등\n제품/상품매출\n용역/서비스제공\n임대수익\n기타\n재고자산매입 등\n용역/서비스비용\n연구비용\n기타\n최상위지배기업\n(주)대웅\n320,503\n133,639\n515,958\n-\n562,371\n27,844,346\n14,763,440\n10,695\n관계기업\n(주)엠디웰아이앤씨\n9,060\n496,313\n14,645\n-\n11,432\n67,335\n136\n94,352\n(주)바이오시네틱스\n-\n-\n-\n-\n-\n370\n1,480\n-\n(주)다나아데이터\n-\n-\n7,200\n-\n-\n-\n-\n-\nImmplacate, Inc.\n-\n-\n-\n14,589\n-\n-\n-\n-\nFreemind Investments\n-\n-\n-\n-\n-\n-\n24,044\n-\n기타특수관계자\n대웅바이오(주)\n13,678,935\n712,050\n-\n-\n40,818,092\n22,948,334\n126,123\n-\n(주)HR그룹\n-\n-\n-\n-\n-\n39,200\n-\n-\n(주)아이디에스앤트러스트\n11,979\n29,232\n74,448\n6,886\n85,933\n583,390\n672,103\n-\n(주)대웅경영개발원\n300\n-\n98,240\n13,952\n3,373\n37,128\n-\n322,462\n(주)대웅생명과학\n-\n-\n-\n-\n351\n-\n-\n314,770\n(주)산웅개발\n132\n-\n-\n-\n22,487\n143,524\n-\n54,025\n(주)대웅개발\n699\n6,171\n596,979\n-\n124,762\n978,655\n1,122\n913,704\n(주)팜팩\n4,361\n-\n170\n-\n1,226,334\n-\n-\n-\n(주)에스티에이치이솔루션\n-\n3,850\n-\n-\n-\n21,799\n-\n29,354\n(주)대웅펫\n64,718\n3,726\n31,840\n-\n1,636\n180,126\n555,006\n48,975\n(주)대웅테라퓨틱스\n16,995\n-\n-\n-\n-\n-\n1,200,000\n-\n(주)디더블유메디팜\n-\n-\n-\n830\n268,314\n-\n79,900\n8,949\n(주)대웅인베스트먼트\n-\n-\n4,718\n10,715\n-\n-\n-\n-\n(주)알피스페이스\n-\n4,791\n-\n-\n351,762\n-\n568\n1,155,756\n(주)알피바이오\n-\n-\n-\n-\n3,882,234\n-\n-\n-\n(주)이지메디컴\n1,692,119\n12,190\n-\n-\n-\n729,140\n8,345\n4,106,823\n(주)시지바이오\n2,577,175\n634,853\n113,400\n204,564\n6,462,499\n178,535\n-\n61,266\n(주)바이오에이지\n501\n1,305\n-\n-\n9,000\n4,078\n9,600\n287,315\n(주)디엔홀딩스\n1,056\n3,132\n17,912\n11,679\n-\n-\n-\n-\n(주)디엔코스메틱스\n1,066,782\n9,961\n23,269\n5,948\n1,267,619\n-\n4,448\n1,498,479\n(주)디엔컴퍼니\n15,226,173\n10,701\n40,995\n-\n-\n532,894\n-\n-\n(주)엠서클\n43,649\n47,743\n58,505\n800\n143,930\n8,937,541\n5,464\n5,289,097\n기타\n1,857,038\n68,912\n79,005\n2,061\n5,223,202\n1,629,883\n129,934\n1,122,484\n합 \xa0계\n36,572,175\n2,178,569\n1,677,284\n272,024\n60,465,331\n64,856,278\n17,581,713\n15,318,506\n[전분기]\n(단위: 천원)\n구 \xa0분\n회사명\n수익 등\n비용 등\n제품/상품매출\n용역/서비스제공\n임대수익\n기타\n재고자산매입 등\n유무형자산매입\n용역/서비스비용\n연구비용\n기타\n최상위지배기업\n(주)대웅\n41,923\n250,782\n442,402\n31,691\n974,862\n-\n27,382,029\n12,624,396\n3,252\n관계기업\n(주)엠디웰아이앤씨\n6,994\n5,735\n9,666\n-\n2,417\n-\n87,932\n-\n109,291\n기타특수관계자\n대웅바이오(주)\n10,908,228\n193,859\n-\n3,426\n35,507,363\n13,080,000\n17,649,680\n144,614\n-\n(주)아이디에스앤트러스트\n364\n49,091\n49,136\n28,478\n96,675\n-\n715,633\n3,654\n7,608\n(주)대웅경영개발원\n295\n-\n354,748\n-\n-\n-\n127,758\n354,049\n185,123\n(주)대웅생명과학\n-\n-\n-\n-\n429\n-\n-\n-\n412,652\n(주)시지바이오\n2,993,121\n169,422\n113,400\n223,079\n6,487,235\n-\n405,988\n-\n41,651\n(주)디엔코스메틱스\n418,441\n24,878\n30,715\n83,400\n912,567\n-\n403\n2,862\n1,730,340\n(주)디엔컴퍼니\n18,935,706\n35,885\n71,668\n-\n-\n-\n618,564\n-\n-\n(주)대웅이엔지\n2,085\n27,836\n1,775\n-\n2,630,204\n-\n252,779\n104,186\n138,107\n(주)산웅개발\n100\n7,364\n12,623\n-\n100,593\n-\n609,044\n-\n130,471\n(주)알피바이오\n-\n-\n-\n-\n5,372,467\n-\n-\n-\n14,209\n(주)이지메디컴\n1,518,790\n22,745\n-\n3,257\n-\n-\n718,247\n4,244\n3,801,667\n(주)대웅개발\n-\n-\n505,754\n-\n-\n-\n-\n-\n335,815\n(주)팜팩\n6,007\n27,545\n765\n-\n4,454,871\n-\n-\n8,650\n-\n(주)엠서클\n13,504\n91,150\n58,138\n4,938\n79,788\n-\n11,019,295\n3,397\n4,425,335\n기타\n1,331,078\n35,039\n86,680\n18,763\n2,094,351\n-\n699,791\n17,731\n2,018,401\n합 \xa0계\n36,176,636\n941,331\n1,737,470\n397,032\n58,713,822\n13,080,000\n60,287,143\n13,267,783\n13,353,922\n""]"
